Search Results 1521-1530 of 14744 for anti-TNF drugs
... medications or prescription anti-platelet agents for 10 days prior to study enrollment. For the 20 volunteers in the anti-platelet agent group, 20 patients ...
There is preclinical evidence for efficacy of nintedanib in SSc and associated ILD (SSc-ILD) and the anti-fibrotic efficacy of nintedanib was proven in ...
... therapy. These drugs help prevent the formation of blood clots, which can cause heart attacks and strokes. The traditional approach is to prescribe ...
Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... - Positive HBsAg, positive anti-HIV, positive HCV RNA at screening ( ...
Mayo Clinic researchers and collaborators used computer simulation and artificial intelligence to virtually screen 30 million drug candidates that may block ...
The purpose of this study is to determine the impact of pulse electromagnetic field (PEMF) therapy using the Bioboosti device (Biomobie Regenerative Medicine ...
Learn about gene therapy for muscular dystrophy in the Virology, Vector and Vaccine Engineering Laboratory of Michael A. Barry, Ph.D., at Mayo Clinic.
"While the primary goal of the study was to safely deliver therapeutic levels of endoxifen, one of the most surprising observations was the prolonged anti ...
By condition, treatment or drug name ... The doses of both drugs received will depend on when the patient is enrolled on to the study. ... an anti-CD38 monoclonal ...
Participation eligibility · Age >18 years. · Histological confirmation of clinically HER2+ breast cancer · Scheduled to start anti-HER2 therapy, in combination ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.